SUPN Latest Press Releases

-- November 2, 2026 --

Supernus and Indivior Complete Merger Creating a Diversified CNS Biopharmaceutical Leader Globe Newswire 9:18 AM

-- October 29, 2026 --

Supernus Announces Third Quarter 2026 Financial Results Globe Newswire 4:05 PM

-- October 28, 2026 --

Updated Effective Date: Huron Consulting Group Set to Join S&P SmallCap 600 PRNewswire 5:44 PM

Chloe Kim Is Changing the Conversation Around ADHD in Women with Qelbree for 'Ms. Represented' Campaign Globe Newswire 8:30 AM

-- October 22, 2026 --

MSG Rangers and Huron Consulting Group Set to Join S&P SmallCap 600 PRNewswire 6:09 PM

-- October 21, 2026 --

Supernus Announces Orphan Drug Exclusivity for ONAPGO (apomorphine HCl) Globe Newswire 7:45 PM

-- October 19, 2026 --

Supernus Pharmaceuticals to Announce Third Quarter 2026 Financial Results and Host Conference Call on October 29, 2026 Globe Newswire 8:30 AM

-- September 25, 2026 --

Are ITGR, BZH, SUPN Obtaining Fair Deals for their Shareholders? PRNewswire 7:38 AM

-- September 24, 2026 --

Supernus Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Supernus Pharmaceuticals, Inc. - SUPN Business Wire 5:16 PM

-- September 2, 2026 --

Supernus Pharmaceuticals to Participate in September Investor Conferences Globe Newswire 4:30 PM

-- August 31, 2026 --

Chloe Kim Teams Up with Qelbree, the #1 Prescribed Branded Non-Stimulant ADHD Treatment*, to Help Empower People Navigating ADHD Globe Newswire 8:30 AM

-- August 29, 2026 --

SUPN Stock Alert: Halper Sadeh LLC is Investigating Whether Supernus Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders Business Wire 7:13 AM

-- August 7, 2026 --

Are BOW, ATKR, SUPN Obtaining Fair Deals for their Shareholders? PRNewswire 5:06 PM

Supernus Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Supernus Pharmaceuticals, Inc. - SUPN Business Wire 11:21 AM

-- August 3, 2026 --

Halper Sadeh LLC is Investigating Whether SUPN, ITGR, BOW are Obtaining Fair Deals for their Shareholders Globe Newswire 4:57 PM

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) PRNewswire 3:13 PM

Are SUPN, ITGR, ATKR, LNTH Obtaining Fair Deals for their Shareholders? PRNewswire 1:41 PM

Shareholder Alert: Ademi LLP investigates whether Supernus Pharmaceuticals, Inc. is obtaining a Fair Price for Public Shareholders PRNewswire 11:41 AM

SUPN Stock Alert: Halper Sadeh LLC is Investigating Whether Supernus Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders Business Wire 10:35 AM

Supernus Announces Second Quarter 2026 Financial Results Globe Newswire 6:35 AM

Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale Globe Newswire 6:30 AM

-- July 22, 2026 --

Supernus Pharmaceuticals to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 4, 2026 Globe Newswire 5:05 PM

-- July 14, 2026 --

Supernus Celebrates Five-Year Anniversary of Qelbree FDA Approval, Continuing to Deliver on Real-World Experience in ADHD Globe Newswire 8:30 AM

-- June 17, 2026 --

Supernus Expands Partnership With MERGE as AI-Powered Agency of Record Globe Newswire 10:15 AM

Market Data Delayed 15 Minutes